Photobiomodulation shows promise as safe and tolerable adjunct therapy for Parkinson’s Disease, recent trial suggests Post author: Post published:December 5, 2023 Post category:uncategorized A safe and feasible treatment option for reducing the motor signs of Parkinson’s disease. You Might Also Like Simple test for flu could improve diagnosis and surveillance June 21, 2024 Deep brain stimulation improves memory and promotes neuron growth in Rett mice October 13, 2023 Can metabolic biomarkers help distinguish between depressive episodes of bipolar disorder and major depressive disorder? October 26, 2023
Can metabolic biomarkers help distinguish between depressive episodes of bipolar disorder and major depressive disorder? October 26, 2023